Federico Grossi Apellis Pharmaceuticals, Inc. (APLS) insider trading activity

Federico Grossi is Chief Medical Officer of Apellis Pharmaceuticals, Inc.. Currently has a direct ownership of 94,884 shares of APLS, which is worth approximately $2.92 Million. The most recent transaction as insider was on Dec 01, 2021, when has been sold 375 shares (Common Stock) at a price of $42.4 per share, resulting in proceeds of $15,900. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 94.9K

0% 3M change

0% 12M change

Total Value Held $2.92 Million

Federico Grossi Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 01 2021	SELL Open market or private sale	$15,900 $42.4 p/Share	375 Reduced 0.58%	64,104 Common Stock
Nov 15 2021	SELL Open market or private sale	$27,188 $43.5 p/Share	625 Reduced 0.96%	64,479 Common Stock
Nov 01 2021	SELL Open market or private sale	$19,188 $30.7 p/Share	625 Reduced 0.96%	64,805 Common Stock
Oct 14 2021	SELL Open market or private sale	$25,927 $34.57 p/Share	750 Reduced 1.13%	65,430 Common Stock
Oct 01 2021	SELL Open market or private sale	$24,945 $33.26 p/Share	750 Reduced 1.12%	66,180 Common Stock
Sep 28 2021	BUY Exercise of conversion of derivative security	$15,040 $3.76 p/Share	4,000 Added 5.64%	66,930 Common Stock
Aug 02 2021	SELL Open market or private sale	$15,998 $63.99 p/Share	250 Reduced 0.4%	62,930 Common Stock
Jul 14 2021	SELL Open market or private sale	$32,340 $64.68 p/Share	500 Reduced 0.79%	63,180 Common Stock
Jul 08 2021	SELL Open market or private sale	$16,420 $65.68 p/Share	250 Reduced 0.39%	63,680 Common Stock
Jun 28 2021	BUY Exercise of conversion of derivative security	$33,840 $3.76 p/Share	9,000 Added 12.34%	63,930 Common Stock
Jun 14 2021	SELL Open market or private sale	$30,920 $61.84 p/Share	500 Reduced 0.9%	54,930 Common Stock
May 14 2021	SELL Open market or private sale	$22,695 $45.39 p/Share	500 Reduced 0.89%	55,430 Common Stock
May 03 2021	SELL Open market or private sale	$30,438 $50.73 p/Share	600 Reduced 1.07%	55,614 Common Stock
Apr 14 2021	SELL Open market or private sale	$21,410 $42.82 p/Share	500 Reduced 0.88%	56,214 Common Stock
Apr 01 2021	SELL Open market or private sale	$26,046 $43.41 p/Share	600 Reduced 1.05%	56,714 Common Stock
Mar 15 2021	SELL Open market or private sale	$23,385 $46.77 p/Share	500 Reduced 0.86%	57,314 Common Stock
Mar 05 2021	SELL Open market or private sale	$243,100 $48.62 p/Share	5,000 Reduced 7.96%	57,814 Common Stock
Mar 05 2021	BUY Exercise of conversion of derivative security	$16,000 $3.2 p/Share	5,000 Added 7.37%	62,814 Common Stock
Mar 01 2021	SELL Open market or private sale	$29,148 $48.58 p/Share	600 Reduced 1.03%	57,814 Common Stock
Feb 16 2021	SELL Open market or private sale	$23,000 $46.0 p/Share	500 Reduced 0.85%	58,414 Common Stock
Feb 10 2021	SELL Payment of exercise price or tax liability	$32,831 $47.72 p/Share	688 Reduced 1.15%	58,914 Common Stock
Feb 01 2021	SELL Open market or private sale	$26,400 $44.0 p/Share	600 Reduced 1.0%	59,602 Common Stock
Jan 28 2021	BUY Grant, award, or other acquisition	-	9,375 Added 13.47%	60,202 Common Stock
Jan 25 2021	BUY Exercise of conversion of derivative security	$52,200 $3.48 p/Share	15,000 Added 22.79%	50,827 Common Stock
Jan 14 2021	SELL Open market or private sale	$207,960 $51.99 p/Share	4,000 Reduced 10.04%	35,827 Common Stock

Federico Grossi

Chief Medical Officer

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APLS shares.

Notify only if

Value

Insider Trading

Get notified when an Apellis Pharmaceuticals, Inc. insider buys or sells APLS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Apellis Pharmaceuticals, Inc.

Track Activities on APLS

Account